Jcr Pharmaceuticals Announces Completion of Clinical Trial Notification Process in Japan for Phase I Study of Jr-441 for Mucopolysaccharidosis Type Iiia
Jcr醫藥宣佈已完成Jr-441用於粘多糖酶病ⅢA型的一期臨床試驗通知程序在日本的報備
Jcr Pharmaceuticals Announces Completion of Clinical Trial Notification Process in Japan for Phase I Study of Jr-441 for Mucopolysaccharidosis Type Iiia
Jcr醫藥宣佈已完成Jr-441用於粘多糖酶病ⅢA型的一期臨床試驗通知程序在日本的報備
譯文內容由第三人軟體翻譯。